GleamWall
中文EN

WST WEST PHARMACEUTICAL SERVICES INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 105770 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY12.6%
TTM net income YoY29.9%
TTM EPS YoY32.0%
Revenue 3-yr CAGR5.1%
Net income 3-yr CAGR4.5%

Margins

Gross margin37.6%
Operating margin23.0%
Net margin18.8%
FCF margin13.3%
EBITDA margin28.4%

Returns

ROE21.2%
ROA15.6%
ROIC (approx.)23.0%
Asset turnover0.83x

Leverage & solvency

Liabilities / assets26.9%
Debt / equity0.07x
Current ratio2.82x
Interest coverage96.32x

Cash quality & payout

Operating cash flow / net income1.02x
Accruals ratio-0.4%
Payout ratio9.8%
Capex / revenue5.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$3.07B$2.89B
Cost of revenue$1.97B$1.89B
Gross profit$1.10B$998.50M
R&D expense$74.30M$69.10M
SG&A expense$393.60M$338.50M
Operating income$584.90M$569.90M
Interest expense$500,000$3.00M
Pretax income$600.90M$585.50M
Income tax$121.60M$107.50M
Net income$493.70M$492.70M
EBITDA$756.30M$725.30M
EPS (basic)6.836.75
EPS (diluted)6.796.69
Dividends declared per share0.860.82
Weighted avg. shares (diluted)72.70M73.70M
Balance sheet
Cash & equivalents$791.30M$484.60M
Receivables$574.40M$552.50M
Inventory$443.90M$377.00M
Current assets$1.98B$1.54B
PP&E, net$1.73B$1.58B
Goodwill$109.90M$106.00M
Intangibles$7.70M$10.80M
Total assets$4.27B$3.64B
Current liabilities$654.90M$550.40M
Short-term debt$0$0
Long-term debt$202.80M$202.60M
Total debt$202.80M$202.60M
Total liabilities$1.09B$961.10M
Shareholders' equity$3.18B$2.68B
Net debt-$588.50M-$282.00M
Shares outstanding72.00M72.30M
Cash flow statement
Operating cash flow$754.80M$653.40M
Capital expenditure$285.90M$377.00M
Free cash flow$468.90M$276.40M
Investing cash flow-$285.90M-$378.70M
Financing cash flow-$185.10M-$622.60M
Depreciation & amortization$171.40M$155.40M
Stock-based compensation$23.80M$18.70M
Dividends paid$61.20M$59.10M
Share buybacks$134.00M$560.90M

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.